Retraction: MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway
- 1Department of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China
- 2Department of Hematology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China
- 3Department of Orthodontics, School of Stomatology, The Fourth Military Medical University, Xi'an, China
- 4Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China
- 5Department of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China
Citation: Wang R, Xu Y, Niu X, Fang Y, Guo D, Chen J, Zhu H, Dong J, Zhao R, Wang Y, Qi B, Ren G, Li X, Liu L and Zhang M (2021) MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway. Front. Physiol. 12:646903. doi: 10.3389/fphys.2021.646903
Received: 28 December 2020; Accepted: 22 February 2021;
Published: 01 April 2021; Retracted: 24 August 2022.
Edited by:
Hao Zhou, People's Liberation Army General Hospital, China